Loading company…
MgShell develops biodegradable medical devices for delivering treatment to the eye.
Founded in 2019 and based in Milan, MgShell develops an injectable, biodegradable, and biocompatible device for treating eye disorders, including an exudative form of age-related macular degeneration. The device releases medication without surgery or external activation. The company raised EUR 500,000 in January 2023 from Bios Line Holding, Club Degli Investitori, and Italian Angels for Biotech to continue research and development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in